STRIDES PHARMA SCIENCE LTD Q3 RESULTS
Strides Pharma Science Q3 net declines 69% to Rs 92 crore
The consolidated income of the company increased to Rs 744.66 crore in the Oct-Dec period.
US-China deal impact on metals undone by coronavirus scare: Siddhartha Khemka
Siddhartha Khemka, Head of Retail Research, MOSL, says if the c...
Our drug Ranitidine is safe: Strides Pharma
Ranitidine is a commonly prescribed medicine for countering acidity and is on the WHO’s Model Lis...
Market Movers: Damani boost to Spencer's, RJ cuts stake in Escorts; airline stocks slip
The broader market performed better, as smallcaps ended flat.
Market Movers: Kotak Q3 spooks bank pack; Voda, realty stocks up, OIL hit
Reliance Industries was the biggest culprit for Monday’s fall, as it bled 146.67 points.
Bayer CropScience Q2 profit rises slightly to Rs 170 crore
Total income rose to Rs 1,356.5 crore against Rs 1,249.1 crore.
Strides Pharma relaunches Ranitidine tablets in US
The company had suspended sales of its generic Ranitidine tablets after the USFDA found contamination in some Ranitidine tablets sold by various companies with potentially cancer causing impurities, NDMA. Strides said now the drug meets the limits prescribed by the US drug regulator.
Strides Pharma shares plunge 8% as company suspends sales of ranitidine tablets in US
On the National Stock Exchange, it cracked 7.94 per cent to close at Rs 302.60.
Stocks in the news: Gati, Bharti Airtel, Alembic Pharma, Aster DM and DHFL
GMR Infra has raised Rs 2,000 crore debt through nonconvertible debentures from Tata Sons.
Why S Naren is betting on small and midcap stocks in power and infra
Smallcaps have better absolute return potential in long term over midcaps & largecaps.
20 firms turned around in Q2! Are they compelling ‘buy’ ideas now?
Seventeen of these 20 stocks posted up to 51 per cent YoY rise in net sales for the quarter.
Strides Pharma Science Q3 profit at Rs 296 crore
Consolidated revenue from operations of the company stood at Rs 794.50 crore.
Bayer CropScience Q3 profit up over twofold
Net income rose to Rs 632 crore during the third quarter of 2018-19.
Sun Pharma Q3 results today: Here's what experts say
Ebitda margins to remain steady QoQ, at 22 per cent, Edelweiss said.
Biocon number six in top 10 Global Biotech Employers ranking for 2019
Biocon continues to be the only company from Asia to feature on the prestigious US-based 'Science' magazine's annual 'Science Careers Top 20 Employers' list, since its debut in 2012.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service